
MTIP leads €11m round for Trialbee
MTIP has led a €11m funding round for Trialbee, a Sweden-based provider of technology used in clinical trials.
Existing investors Industrifonden and Briban Invest also participated.
MTIP is currently investing from MTIP Fund II, a vehicle that held a first close in November 2019 on CHF 30m. The fund expects to hold a final close in 2020. It invests up to €25m in return for 10-30% stakes, accumulated over several funding rounds, according to Unquote Data.
The funding round brings the total amount raised by Trialbee to €25m.
The fresh capital will be used to further accelerate the company's growth and enhance its technology platform.
Previous funding
In December 2013, Trialbee raised €2.5m from unknown investors. Subsequently, the company raised $5m in a series-A round from Industrifonden and Briban.
Company
Founded in 2010 and headquartered in Malmö, Trialbee provides technology for patient matching and engagement in clinical trials. The company has 50 employees in its Malmö and North Carolina offices, according to LinkedIn.
People
MTIP – Christoph Kausch (CEO, founding partner); David Germonpré (investment partner).
Trialbee – Lollo Eriksson (CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater